BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 2562220)

  • 1. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct cloning of leucine zipper proteins: Jun binds cooperatively to the CRE with CRE-BP1.
    Macgregor PF; Abate C; Curran T
    Oncogene; 1990 Apr; 5(4):451-8. PubMed ID: 2139203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH; Chen TK; Birrer MJ
    Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single site mutation in a truncated Fos protein allows it to interact with the TRE in vitro.
    Nicklin MJ; Casari G
    Oncogene; 1991 Jan; 6(1):173-9. PubMed ID: 1899479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.
    Sassone-Corsi P; Ransone LJ; Verma IM
    Oncogene; 1990 Mar; 5(3):427-31. PubMed ID: 2107494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. fos and jun interaction: the role of the leucine zipper.
    Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
    Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins.
    Kerppola TK; Curran T
    Oncogene; 1994 Nov; 9(11):3149-58. PubMed ID: 7936637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA.
    Weiss MA; Ellenberger T; Wobbe CR; Lee JP; Harrison SC; Struhl K
    Nature; 1990 Oct; 347(6293):575-8. PubMed ID: 2145515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of functional domains in Fos and Jun proteins using epitope-specific antibodies.
    Adamkiewicz J; Brüller HJ; Gausepohl H; Frank R; Müller R
    Oncogene; 1990 Apr; 5(4):525-33. PubMed ID: 1691478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental expression of the Xenopus laevis fos protooncogene.
    Kindy MS; Verma IM
    Cell Growth Differ; 1990 Jan; 1(1):27-37. PubMed ID: 2127691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis of the DNA contact site in Fos protein: compatibility with the scissors grip model and requirement for transformation.
    Neuberg M; Schuermann M; Müller R
    Oncogene; 1991 Aug; 6(8):1325-33. PubMed ID: 1909428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.
    Sassone-Corsi P; Ransone LJ; Lamph WW; Verma IM
    Nature; 1988 Dec; 336(6200):692-5. PubMed ID: 3143919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.